HSBC Holdings’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-24,867
| Closed | -$1.53M | – | 3144 |
|
|
2025
Q4 | $1.53M | Buy |
24,867
+4,660
| +23% | +$285K | ﹤0.01% | 1700 |
|
|
2025
Q3 | $1.25M | Sell |
20,207
-17,384
| -46% | -$1.21M | ﹤0.01% | 1710 |
|
|
2025
Q2 | $2.99M | Buy |
37,591
+4,315
| +13% | +$361K | ﹤0.01% | 1336 |
|
|
2025
Q1 | $2.86M | Sell |
33,276
-9,406
| -22% | -$772K | ﹤0.01% | 1314 |
|
|
2024
Q4 | $3.32M | Buy |
42,682
+29,398
| +221% | +$2.28M | ﹤0.01% | 1282 |
|
|
2024
Q3 | $952K | Buy |
13,284
+4,206
| +46% | +$298K | ﹤0.01% | 1723 |
|
|
2024
Q2 | $630K | Sell |
9,078
-15,209
| -63% | -$1.03M | ﹤0.01% | 1864 |
|
|
2024
Q1 | $1.76M | Buy |
24,287
+237
| +1% | +$15.8K | ﹤0.01% | 1539 |
|
|
2023
Q4 | $1.47M | Buy |
24,050
+1,975
| +9% | +$117K | ﹤0.01% | 1614 |
|
|
2023
Q3 | $1.26M | Buy |
22,075
+3,226
| +17% | +$195K | ﹤0.01% | 1629 |
|
|
2023
Q2 | $1.13M | Sell |
18,849
-1,628
| -8% | -$97.4K | ﹤0.01% | 1663 |
|
|
2023
Q1 | $1.27M | Sell |
20,477
-24,948
| -55% | -$1.56M | ﹤0.01% | 1679 |
|
|
2022
Q4 | $2.86M | Buy |
45,425
+35,641
| +364% | +$2.04M | ﹤0.01% | 1526 |
|
|
2022
Q3 | $493K | Buy |
9,784
+2,257
| +30% | +$125K | ﹤0.01% | 2170 |
|
|
2022
Q2 | $438K | Sell |
7,527
-4,392
| -37% | -$242K | ﹤0.01% | 2407 |
|
|
2022
Q1 | $637K | Sell |
11,919
-3,894
| -25% | -$225K | ﹤0.01% | 2236 |
|
|
2021
Q4 | $962K | Buy |
15,813
+8,766
| +124% | +$520K | ﹤0.01% | 2079 |
|
|
2021
Q3 | $401K | Sell |
7,047
-719
| -9% | -$39.5K | ﹤0.01% | 2385 |
|
|
2021
Q2 | $408K | Buy |
7,766
+3,166
| +69% | +$152K | ﹤0.01% | 2316 |
|
|
2021
Q1 | $203K | Sell |
4,600
-12,952
| -74% | -$544K | ﹤0.01% | 2541 |
|
|
2020
Q4 | $611K | Buy |
17,552
+7,983
| +83% | +$283K | ﹤0.01% | 2050 |
|
|
2020
Q3 | $348K | Sell |
9,569
-3,673
| -28% | -$137K | ﹤0.01% | 2162 |
|
|
2020
Q2 | $497K | Buy |
13,242
+7,004
| +112% | +$280K | ﹤0.01% | 1837 |
|
|
2020
Q1 | $226K | Sell |
6,238
-2,593
| -29% | -$101K | ﹤0.01% | 2222 |
|
|
2019
Q4 | $361K | Sell |
8,831
-30,738
| -78% | -$1.15M | ﹤0.01% | 2422 |
|
|
2019
Q3 | $1.37M | Buy |
+39,569
| New | +$1.3M | ﹤0.01% | 1794 |
|
|
2018
Q1 | – | Sell |
-45,365
| Closed | -$2.02M | – | 2587 |
|
|
2017
Q4 | $2.02M | Buy |
+45,365
| New | +$2.07M | ﹤0.01% | 1106 |
|
|
2017
Q1 | – | Sell |
-9,440
| Closed | -$492K | – | 2463 |
|
|
2016
Q4 | $492K | Buy |
+9,440
| New | +$456K | ﹤0.01% | 1851 |
|
Other funds holding PBH
AI
VPM
VCM
HSBC Holdings's PBH Position: Q1 2026 in Review
HSBC Holdings sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 24,867 shares — an estimated $1.53M sold.
HSBC Holdings first reported a position in PBH in Q4 2016 and held it in 28 quarters. The position peaked at $3.32M in Q4 2024. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.
- HSBC Holdings reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
- HSBC Holdings sold 24,867 Prestige Consumer Healthcare shares in Q1 2026, an estimated $1.53M.
- HSBC Holdings first reported a position in Prestige Consumer Healthcare in Q4 2016 and held it in 28 quarters.
- HSBC Holdings's Prestige Consumer Healthcare position peaked at $3.32M in Q4 2024.
- 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.